These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23261978)

  • 1. Gene transfer for congestive heart failure: update 2013.
    Tang T; Hammond HK
    Transl Res; 2013 Apr; 161(4):313-20. PubMed ID: 23261978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for heart failure.
    Thompson RB; Rungwerth K; Koch WJ
    Ann Med; 2004; 36 Suppl 1():106-15. PubMed ID: 15176432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects for gene transfer for clinical heart failure.
    Tang T; Gao MH; Hammond HK
    Gene Ther; 2012 Jun; 19(6):606-12. PubMed ID: 22534469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking caspase-activated apoptosis improves contractility in failing myocardium.
    Laugwitz KL; Moretti A; Weig HJ; Gillitzer A; Pinkernell K; Ott T; Pragst I; Städele C; Seyfarth M; Schömig A; Ungerer M
    Hum Gene Ther; 2001 Nov; 12(17):2051-63. PubMed ID: 11747596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescuing the failing heart by targeted gene transfer.
    Kawase Y; Ladage D; Hajjar RJ
    J Am Coll Cardiol; 2011 Mar; 57(10):1169-80. PubMed ID: 21371634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urocortin 3 Gene Transfer Increases Function of the Failing Murine Heart.
    Giamouridis D; Gao MH; Lai NC; Tan Z; Kim YC; Guo T; Miyanohara A; Blankesteijn MW; Biessen EAL; Hammond HK
    Hum Gene Ther; 2019 Jan; 30(1):10-20. PubMed ID: 30003813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in gene-based therapy for heart failure.
    Ly HQ; Kawase Y; Hajjar RJ
    J Cardiovasc Transl Res; 2008 Jun; 1(2):127-36. PubMed ID: 20559907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure.
    del Monte F; Williams E; Lebeche D; Schmidt U; Rosenzweig A; Gwathmey JK; Lewandowski ED; Hajjar RJ
    Circulation; 2001 Sep; 104(12):1424-9. PubMed ID: 11560860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. Approaches and perspectives.
    Poller W; Fechner H; Kurreck J; Pauschinger M; Kühl U; Erdmann VA; Lamers JM; Schultheiss HP
    Z Kardiol; 2004 Mar; 93(3):171-93. PubMed ID: 15024585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium regulatory proteins and their alteration by transgenic approaches.
    Dillmann WH
    Am J Cardiol; 1999 Jun; 83(12A):89H-91H. PubMed ID: 10750595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in gene therapy for heart failure.
    Fish KM; Ishikawa K
    Discov Med; 2015 Apr; 19(105):285-91. PubMed ID: 25977191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A translatable, closed recirculation system for AAV6 vector-mediated myocardial gene delivery in the large animal.
    Swain JD; Katz MG; White JD; Thesier DM; Henderson A; Stedman HH; Bridges CR
    Methods Mol Biol; 2011; 709():331-54. PubMed ID: 21194039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model.
    Pleger ST; Shan C; Ksienzyk J; Bekeredjian R; Boekstegers P; Hinkel R; Schinkel S; Leuchs B; Ludwig J; Qiu G; Weber C; Raake P; Koch WJ; Katus HA; Müller OJ; Most P
    Sci Transl Med; 2011 Jul; 3(92):92ra64. PubMed ID: 21775667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond small molecule drugs for heart failure: prospects for gene therapy.
    Chien KR
    Novartis Found Symp; 2006; 274():244-56; discussion 256-9, 272-6. PubMed ID: 17019816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramyocardial injection of SERCA2a-expressing lentivirus improves myocardial function in doxorubicin-induced heart failure.
    Mattila M; Koskenvuo J; Söderström M; Eerola K; Savontaus M
    J Gene Med; 2016 Jul; 18(7):124-33. PubMed ID: 27203155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting phospholamban by gene transfer in human heart failure.
    del Monte F; Harding SE; Dec GW; Gwathmey JK; Hajjar RJ
    Circulation; 2002 Feb; 105(8):904-7. PubMed ID: 11864915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for heart failure.
    Greenberg B
    J Cardiol; 2015 Sep; 66(3):195-200. PubMed ID: 25818479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling.
    Fish KM; Ladage D; Kawase Y; Karakikes I; Jeong D; Ly H; Ishikawa K; Hadri L; Tilemann L; Muller-Ehmsen J; Samulski RJ; Kranias EG; Hajjar RJ
    Circ Heart Fail; 2013 Mar; 6(2):310-7. PubMed ID: 23271792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting signaling pathways in heart failure by gene transfer.
    MacNeill BD; Hayase M; Hajjar RJ
    Curr Atheroscler Rep; 2003 May; 5(3):178-85. PubMed ID: 12667429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [GENE THERAPY POTENTIAL AS A TREATMENT FOR HEART FAILURE].
    Katz MG; Hadas Y; Fargnoli AS; Hadas S; Zangi L; Bridges CR
    Harefuah; 2018 Feb; 157(2):112-116. PubMed ID: 29484868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.